CAITRIN STANDRING: Open Payments
NPI 1083159487 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,893 in 90 payments from 20 companies in 2025. Trend: 2023 $921 · 2024 $1,424 · 2025 $1,893
Food & beverage: $1,698Education: $195
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $392 |
| ABBVIE INC. | 17 | $336 |
| Galderma Laboratories, L.P. | 10 | $146 |
| Novartis Pharmaceuticals Corporation | 5 | $131 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $82 |
| UCB, Inc. | 3 | $82 |
| Arcutis Biotherapeutics, Inc. | 5 | $78 |
| GENZYME CORPORATION | 2 | $77 |
| Botanix SB Inc | 4 | $72 |
| Amgen Inc. | 4 | $72 |
Products named: TREMFYA, RINVOQ, DUPIXENT, SKYRIZI, Bimzelx, Zoryve, AKLIEF, SOFDRA.
Industry payments across IL — which companies pay providers there.
